← Browse by Condition
Medical Condition

transplant complication

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 4, Phase 2

ClinicalMetric tracks all active clinical trials for transplant complication sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — transplant complication Clinical Trials

How many clinical trials are currently recruiting for transplant complication?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for transplant complication, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for transplant complication?
transplant complication research spans Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a transplant complication clinical trial?
Eligibility criteria for transplant complication trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 4
1
Top Sponsors
Centro Hospitalar De São João, E.P.E. 1 trial
Peking University People's Hospital 1 trial
MaaT Pharma 1 trial

Recruiting Clinical Trials

NCT07065734 Phase 4
Recruiting

NEgative prEssure Wound Therapy in Renal Transplant

Enrollment
150 pts
Location
Portugal
Sponsor
Centro Hospitalar De São João,...
View Trial →
NCT07349498
Recruiting

Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation

Enrollment
10,000 pts
Location
China
Sponsor
Peking University People's Hos...
View Trial →
NCT05762211 Phase 2
Recruiting

Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial)

Enrollment
387 pts
Location
Belgium, France, Ger...
Sponsor
MaaT Pharma
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology